News

Company further enhance 3rd Party Logistics commercial support services for niche / orphan drugs.

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new technique for fighting deadly and hard-to-treat pancreatic cancer.

Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.

'Resistance breaker’ compounds have been described as the most important innovation in the discovery of new antibiotics since Alexander Fleming’s original breakthrough.

The companies will commence research against a new clinically significant target involving the discovery of novel small molecules that modulate protein-protein interaction.

Agilent Technologies reported orders up 4 percent over one year ago to $1.83 billion with revenues of $1.72 billion, down 3 percent compared with one year ago.

Microwave-assisted synthesis has revolutionized many processes in recent years as a valuable alternative to the use of conductive heating.

Zaiput awards $10,000 in grants to three of the most prominent flow chemistry research groups worldwide.

OBN appoints senior buyer for member companies.

Asymmetrical particles could make lab-on-a-chip diagnostic devices more efficient and portable.